High Content Screening

¡ Methods in molecular biology āĻ•āĻŋāϤāĻžāĻĒ 356 ¡ Springer Science & Business Media
āχāĻŦ⧁āĻ•
464
āĻĒ⧃āĻˇā§āĻ āĻž
āĻŽā§‚āĻ˛ā§āϝāĻžāĻ‚āĻ•āύ āφ⧰⧁ āĻĒā§°ā§āϝāĻžāϞ⧋āϚāύāĻž āϏāĻ¤ā§āϝāĻžāĻĒāύ āϕ⧰āĻž āĻšā§‹ā§ąāĻž āύāĻžāχ  āĻ…āϧāĻŋāĻ• āϜāĻžāύāĻ•

āĻāχ āχāĻŦ⧁āĻ•āĻ–āύ⧰ āĻŦāĻŋāĻˇā§Ÿā§‡

There has always been some tension between proponents of hypothesis-driven and discovery-driven research in the broad field of life sciences. Academic research has been primarily focused on hypothesis-driven research. However, the success of the human genome project, a discovery-driven research approach, has opened the door to adding other types of discovery-driven research to a continuum of research approaches. In contrast, drug discovery research in the pharmaceutical industry has embraced discovery-driven research for many years. A good example has been the discovery of active compounds from large chemical libraries, through screening campaigns. The success of the human genome project has also demonstrated the need for both academic researchers and industrial researchers to now understand the functions of genes and gene products. The cell is the basic unit of life and it has been at the cellular level where function can be demonstrated most cost-effectively and rapidly. High content screening (HCS) was developed by Cellomics Inc. in the mid-1990s to address the need for a platform that could be used in the discovery-driven research and development required to understand the functions of genes and gene products at the level of the cell.

āĻāχ āχāĻŦ⧁āĻ•āĻ–āύāĻ• āĻŽā§‚āĻ˛ā§āϝāĻžāĻ‚āĻ•āύ āϕ⧰āĻ•

āφāĻŽāĻžāĻ• āφāĻĒā§‹āύāĻžā§° āĻŽāϤāĻžāĻŽāϤ āϜāύāĻžāĻ“āĻ•āĨ¤

āĻĒāĻĸāĻŧāĻžā§° āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻžā§ąāϞ⧀

āĻ¸ā§āĻŽāĻžā§°ā§āϟāĻĢ’āύ āφ⧰⧁ āĻŸā§‡āĻŦāϞ⧇āϟ
Android āφ⧰⧁ iPad/iPhoneā§° āĻŦāĻžāĻŦ⧇ Google Play Books āĻāĻĒāĻŸā§‹ āχāύāĻˇā§āϟāϞ āϕ⧰āĻ•āĨ¤ āχ āĻ¸ā§āĻŦāϝāĻŧāĻ‚āĻ•ā§āϰāĻŋāϝāĻŧāĻ­āĻžā§ąā§‡ āφāĻĒā§‹āύāĻžā§° āĻāĻ•āĻžāωāĻŖā§āϟ⧰ āϏ⧈āϤ⧇ āĻ›āĻŋāĻ‚āĻ• āĻšāϝāĻŧ āφ⧰⧁ āφāĻĒ⧁āύāĻŋ āϝ'āϤ⧇ āύāĻžāĻĨāĻžāĻ•āĻ• āϤ'āϤ⧇āχ āϕ⧋āύ⧋ āĻ…āĻĄāĻŋāĻ…'āĻŦ⧁āĻ• āĻ…āύāϞāĻžāχāύ āĻŦāĻž āĻ…āĻĢāϞāĻžāχāύāϤ āĻļ⧁āύāĻŋāĻŦāϞ⧈ āϏ⧁āĻŦāĻŋāϧāĻž āĻĻāĻŋāϝāĻŧ⧇āĨ¤
āϞ⧇āĻĒāϟāĻĒ āφ⧰⧁ āĻ•āĻŽā§āĻĒāĻŋāωāϟāĻžā§°
āφāĻĒ⧁āύāĻŋ āĻ•āĻŽā§āĻĒāĻŋāωāϟāĻžā§°ā§° ā§ąā§‡āĻŦ āĻŦā§āϰāĻžāωāϜāĻžā§° āĻŦā§āĻ¯ā§ąāĻšāĻžā§° āϕ⧰āĻŋ Google PlayāϤ āĻ•āĻŋāύāĻž āĻ…āĻĄāĻŋāĻ…'āĻŦ⧁āĻ•āϏāĻŽā§‚āĻš āĻļ⧁āύāĻŋāĻŦ āĻĒāĻžā§°ā§‡āĨ¤
āχ-ā§°ā§€āĻĄāĻžā§° āφ⧰⧁ āĻ…āĻ¨ā§āϝ āĻĄāĻŋāĻ­āĻžāχāϚ
Kobo eReadersā§° āĻĻ⧰⧇ āχ-āϚāĻŋ⧟āĻžāρāĻšā§€ā§° āĻĄāĻŋāĻ­āĻžāχāϚāϏāĻŽā§‚āĻšāϤ āĻĒā§āĻŋāĻŦāϞ⧈, āφāĻĒ⧁āύāĻŋ āĻāϟāĻž āĻĢāĻžāχāϞ āĻĄāĻžāωāύāĻ˛â€™āĻĄ āϕ⧰āĻŋ āϏ⧇āχāĻŸā§‹ āφāĻĒā§‹āύāĻžā§° āĻĄāĻŋāĻ­āĻžāχāϚāϞ⧈ āĻ¸ā§āĻĨāĻžāύāĻžāĻ¨ā§āϤ⧰āĻŖ āϕ⧰āĻŋāĻŦ āϞāĻžāĻ—āĻŋāĻŦāĨ¤ āϏāĻŽā§°ā§āĻĨāĻŋāϤ āχ-ā§°āĻŋāĻĄāĻžā§°āϞ⧈ āĻĢāĻžāχāϞāĻŸā§‹ āϕ⧇āύ⧇āĻ•ā§ˆ āĻ¸ā§āĻĨāĻžāύāĻžāĻ¨ā§āϤ⧰ āϕ⧰āĻŋāĻŦ āϜāĻžāύāĻŋāĻŦāϞ⧈ āϏāĻšāĻžāϝāĻŧ āϕ⧇āĻ¨ā§āĻĻā§ā§°āϤ āĻĨāĻ•āĻž āϏāĻŦāĻŋāĻļ⧇āώ āύāĻŋā§°ā§āĻĻ⧇āĻļāĻžā§ąāϞ⧀ āϚāĻžāĻ“āĻ•āĨ¤

āĻ›āĻŋā§°āĻŋāϜāĻŸā§‹ āĻ…āĻŦā§āϝāĻžāĻšāϤ ā§°āĻžāĻ–āĻ•

D. Lansing Taylorā§° āĻĻā§āĻŦāĻžā§°āĻž āφ⧰⧁ āĻ…āϧāĻŋāĻ•

āĻāϕ⧇āϧ⧰āĻŖā§° āχ-āĻŦ⧁āĻ•